NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The global neuromuscular disease therapeutics market size is estimated to grow by USD 13.7 billion from ...

A new Pediatric Research reflection by Alex Smith traces nearly twenty years of living alongside his son Harrison's Duchenne ...

Every movement we make, whether walking, speaking or even breathing, depends on the health of our muscles and nerves. For people living with one of the more than 300 rare conditions known as ...

For people with muscular dystrophy, who may experience problems with muscle strength, endurance, balance, joint stiffness, ...

IntroductionIn the first part of the intermediate level, we covered nutritional support for people with dementia. In this ...

A new clinical study shows that third-generation long-read sequencing matches conventional tests perfectly while revealing ...

Biotechs developing therapeutics to treat rare diseases include two that received FDA approvals this year for drugs to treat ...

Adeno-associated virus (AAV)–mediated gene therapy was one of the focal points of this year's Muscular Dystrophy Association conference. Here, Barry Byrne, MD, PhD, University of Florida, speaks to ...

・The acquisition includes Edgewise’s muscular dystrophy operations and its lead drug candidate, Sevasemten. ・Sevasemten is currently being evaluated in a pivotal trial for Becker muscular dystrophy ...

New York, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today the awarding of 21 new grants with a total funding commitment of over $5 million toward ...

THURSDAY, Oct. 23, 2025 (HealthDay News) — Autoimmune neuromuscular diseases may sound complex, but understanding them is the first step to getting the right care and support. Conditions such as ...

Annual campaign gives shoppers an opportunity to turn everyday purchases into meaningful impact for people living with muscular dystrophy, ALS and related neuromuscular diseases. NEW YORK – Wednesday, ...